{"id":552543,"date":"2026-07-31T06:23:11","date_gmt":"2026-07-31T06:23:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/552543\/"},"modified":"2026-07-31T06:23:11","modified_gmt":"2026-07-31T06:23:11","slug":"auckland-scientists-on-cusp-of-exciting-new-cancer-drug","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/552543\/","title":{"rendered":"Auckland scientists on cusp of \u2018exciting\u2019 new cancer drug"},"content":{"rendered":"<p class=\"wp-block-paragraph\">A new cancer treatment drug that has shown a 30 to 60% cure rate in laboratory models of cancer is cause for excitement for a University of Auckland team of scientists.<\/p>\n<p class=\"wp-block-paragraph\">The team has carried out early experiments on a new cancer drug which they say has displayed precisely that level of promise.<\/p>\n<p class=\"wp-block-paragraph\">The research is being led by Associate Professors Jeff Smaill and Adam Patterson from the Department of Cancer Sciences, and Malaghan Institute Professor Ian Hermans.<\/p>\n<p class=\"wp-block-paragraph\">\u201cIt\u2019s early days, but we\u2019re seeing long-term eradication of cancer in lab experiments using this new drug,\u201d says Assoc Prof Smaill.<\/p>\n<p class=\"wp-block-paragraph\">\u201cIt\u2019s exciting to see that once the cancer is cured, if we try to reintroduce the same type of cancer, it won\u2019t establish a second time.<\/p>\n<p class=\"wp-block-paragraph\">\u201cSo this treatment looks promising in terms of preventing relapse.\u201d<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"576\" alt=\"\" class=\"wp-image-35659 lazyload\" src=\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/07\/1783986028594.jpg\"  data- data-eio-rwidth=\"1024\" data-eio-rheight=\"576\"\/><br \/>Associate Professors Jeff Smaill and Adam Patterson are developing a new drug to treat lung cancer (Image: Rose Davis).<\/p>\n<p class=\"wp-block-paragraph\">The drug gives a unique boost to the body\u2019s immune defences, mobilising them inside tumours to help fight cancer, says Assoc Prof Patterson.<\/p>\n<p class=\"wp-block-paragraph\">While the new treatment is currently being targeted at lung cancer, it could be used to increase the chances of surviving many types of cancer, he said.<\/p>\n<p class=\"wp-block-paragraph\">To further develop the drug, the team has just launched a new company, Stave Therapeutics, which has attracted investment from Unruly Partners.<\/p>\n<p class=\"wp-block-paragraph\">The scientists hope to optimise the drug\u2019s potential, before launching world-first clinical trials with cancer patients within the next two years.<\/p>\n<p class=\"wp-block-paragraph\">Over the past 15 years, immunotherapy drugs have been created that help treat about 20 different cancers. However, they are only effective long-term for about 20 to 25% of lung cancer patients and for about 5 to 15% of patients with other major types of cancer.<\/p>\n<p class=\"wp-block-paragraph\">Assoc Prof Smaill says the team is \u201clike a dog with a bone\u201d, relentlessly looking for ways to develop treatments that are more effective for more patients.<\/p>\n<p class=\"wp-block-paragraph\">Their innovative approach involves turning \u2018cold tumours\u2019, which few immune cells have infiltrated, into \u2018hot tumours\u2019, which are inflamed by armies of immune cells attacking the cancer, says Prof Hermans.<\/p>\n<p class=\"wp-block-paragraph\">\u201cWe\u2019ve been working on a way to stimulate immune cells in the tumour, even if there are very few of them,\u201d he said.<\/p>\n<p class=\"wp-block-paragraph\">\u201cWe want to get them to release the signalling molecules that make a tumour hotter, more inflamed, that attract immune cell penetration into the tumour.\u201d<\/p>\n<p class=\"wp-block-paragraph\">Trials in laboratory models that don\u2019t respond to existing immunotherapy drugs have been promising, says Assoc Prof Patterson.<\/p>\n<p class=\"wp-block-paragraph\">They show the new drug stimulates the body\u2019s immune defences and increases the number of T cells entering the tumour to fight cancer cells.<\/p>\n<p class=\"wp-block-paragraph\">Stronger immune responses are activated when the new compound is used in combination with existing immunotherapy drugs that stop cancers turning off the body\u2019s immune defences, says Assoc Prof Patterson.<\/p>\n<p class=\"wp-block-paragraph\">\u201cWe think converting tumours from cold to hot is going to be the real way to get immunotherapy working better.\u201d<\/p>\n<p class=\"wp-block-paragraph\">\u201cIf we can achieve this, we can make a big impact on treating a lot of different cancers.\u201d<\/p>\n<p class=\"wp-block-paragraph\">Over the past 30 years at the University\u2019s Auckland Cancer Society Research Centre and as members of the Centre for Cancer Research, the Associate Professors have created six new cancer drugs that have reached the stage of clinical trials.<\/p>\n<p class=\"wp-block-paragraph\">Assoc Prof Smaill worked with pharmaceutical company, Pfizer, to discover dacomitinib, a lung cancer treatment that gained global approval for patient use in 2018.<\/p>\n<p class=\"wp-block-paragraph\">Two new drugs the pair have developed to treat a range of cancers are undergoing phase one clinical trials in Europe and China. They developed a third cancer drug, tarloxotinib, which has advanced to phase two clinical trials in the United States, Australia, Canada and Hong Kong.<\/p>\n<p class=\"wp-block-paragraph\">In 2021, funding from Maurice Wilkins Centre helped launch their latest research, followed by a $1.2 million Health Research Council grant. Last year the Ministry for Business, Innovation and Employment granted more than $5 million over three years for the project. Cancer Society Auckland Northland has also provided significant funding supporting their research.<\/p>\n<p class=\"wp-block-paragraph\">\u201cWe\u2019ve been backing this research for years because discoveries like this give cancer patients hope. Our vision is for a future free from cancer,\u201d says Cancer Society Auckland Northland chief executive, Andrew Young.<\/p>\n<p class=\"wp-block-paragraph\">Over the next 18 months, Stave Therapeutics plans to test hundreds of compounds to optimise the treatment\u2019s potency and reduce potential side effects.<\/p>\n<p class=\"wp-block-paragraph\">\u201cIt\u2019s still early days, but we\u2019re pretty amped up about this one,\u201d says Assoc Prof Smaill.<\/p>\n<p class=\"wp-block-paragraph\">\u201cWhen you\u2019re designing new molecules the universe has never seen before and you\u2019re controlling the chemical structure to make things happen in ways you can predict, it\u2019s a real buzz.<\/p>\n<p class=\"wp-block-paragraph\">\u201cThere\u2019s always a rush when you go: We\u2019ve doubled the potency, or we\u2019ve increased the selectivity, or we\u2019re seeing a 60 percent cure rate in our lab experiments.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"A new cancer treatment drug that has shown a 30 to 60% cure rate in laboratory models of&hellip;\n","protected":false},"author":2,"featured_media":552544,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[134,111,139,69],"class_list":["post-552543","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/552543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=552543"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/552543\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/552544"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=552543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=552543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=552543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}